Cerus Total Assets 2010-2024 | CERS
Cerus total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
| Cerus Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $198 |
| 2022 | $218 |
| 2021 | $237 |
| 2020 | $221 |
| 2019 | $166 |
| 2018 | $163 |
| 2017 | $98 |
| 2016 | $103 |
| 2015 | $139 |
| 2014 | $82 |
| 2013 | $83 |
| 2012 | $49 |
| 2011 | $45 |
| 2010 | $48 |
| 2009 | $34 |
| Cerus Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $190 |
| 2024-06-30 | $185 |
| 2024-03-31 | $189 |
| 2023-12-31 | $198 |
| 2023-09-30 | $206 |
| 2023-06-30 | $199 |
| 2023-03-31 | $209 |
| 2022-12-31 | $218 |
| 2022-09-30 | $215 |
| 2022-06-30 | $216 |
| 2022-03-31 | $222 |
| 2021-12-31 | $237 |
| 2021-09-30 | $219 |
| 2021-06-30 | $223 |
| 2021-03-31 | $221 |
| 2020-12-31 | $221 |
| 2020-09-30 | $213 |
| 2020-06-30 | $215 |
| 2020-03-31 | $215 |
| 2019-12-31 | $166 |
| 2019-09-30 | $164 |
| 2019-06-30 | $175 |
| 2019-03-31 | $176 |
| 2018-12-31 | $163 |
| 2018-09-30 | $162 |
| 2018-06-30 | $152 |
| 2018-03-31 | $144 |
| 2017-12-31 | $98 |
| 2017-09-30 | $97 |
| 2017-06-30 | $83 |
| 2017-03-31 | $85 |
| 2016-12-31 | $103 |
| 2016-09-30 | $116 |
| 2016-06-30 | $120 |
| 2016-03-31 | $128 |
| 2015-12-31 | $139 |
| 2015-09-30 | $135 |
| 2015-06-30 | $151 |
| 2015-03-31 | $143 |
| 2014-12-31 | $82 |
| 2014-09-30 | $79 |
| 2014-06-30 | $77 |
| 2014-03-31 | $73 |
| 2013-12-31 | $83 |
| 2013-09-30 | $79 |
| 2013-06-30 | $83 |
| 2013-03-31 | $92 |
| 2012-12-31 | $49 |
| 2012-09-30 | $49 |
| 2012-06-30 | $46 |
| 2012-03-31 | $52 |
| 2011-12-31 | $45 |
| 2011-09-30 | $37 |
| 2011-06-30 | $39 |
| 2011-03-31 | $46 |
| 2010-12-31 | $48 |
| 2010-09-30 | $32 |
| 2010-06-30 | $30 |
| 2010-03-31 | $32 |
| 2009-12-31 | $34 |
| 2009-09-30 | $43 |
| 2009-06-30 | $35 |
| 2009-03-31 | $39 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.336B | $0.156B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.284B | 25.22 |
| Stryker (SYK) | United States | $148.861B | 33.55 |
| Boston Scientific (BSX) | United States | $147.840B | 42.50 |
| EssilorLuxottica (ESLOY) | France | $120.398B | 0.00 |
| Medtronic (MDT) | Ireland | $112.636B | 16.73 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.153B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.736B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $39.899B | 20.69 |
| ResMed (RMD) | United States | $36.307B | 29.83 |
| Terumo (TRUMY) | Japan | $28.860B | 40.76 |
| Koninklijke Philips (PHG) | Netherlands | $24.692B | 18.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.842B | 13.91 |
| Insulet (PODD) | United States | $19.563B | 77.90 |
| Baxter (BAX) | United States | $16.252B | 10.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.094B | 34.30 |
| BellRing Brands (BRBR) | United States | $9.817B | 39.50 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.632B | 15.41 |
| ICU Medical (ICUI) | United States | $4.089B | 38.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.823B | 19.01 |
| Haemonetics (HAE) | United States | $3.684B | 17.98 |
| Envista Holdings (NVST) | United States | $3.623B | 26.99 |
| Perrigo (PRGO) | Ireland | $3.281B | 9.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.992B | 19.25 |
| GN Store Nord (GNNDY) | Denmark | $2.797B | 17.94 |
| Neogen (NEOG) | United States | $2.592B | 29.88 |
| LeMaitre Vascular (LMAT) | United States | $2.203B | 53.55 |
| AtriCure (ATRC) | United States | $1.926B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.514B | 26.50 |
| InMode (INMD) | Israel | $1.434B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.368B | 9.78 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.343B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
| Owens & Minor (OMI) | United States | $1.145B | 8.95 |
| Curaleaf Holdings (CURLF) | Canada | $0.903B | 0.00 |
| Evolus (EOLS) | United States | $0.895B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.881B | 15.54 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.678B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.572B | 25.24 |
| Omeros (OMER) | United States | $0.538B | 0.00 |
| Surmodics (SRDX) | United States | $0.530B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.418B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.91 |
| Quanterix (QTRX) | United States | $0.386B | 0.00 |
| Valneva SE (VALN) | France | $0.376B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Biote (BTMD) | United States | $0.307B | 6.73 |
| OraSure Technologies (OSUR) | United States | $0.290B | 19.45 |
| Canopy Growth (CGC) | Canada | $0.263B | 0.00 |
| Zynex (ZYXI) | United States | $0.261B | 54.53 |
| High Tide (HITI) | Canada | $0.244B | 100.33 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.71 |
| Aurora Cannabis (ACB) | Canada | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 110.50 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| MacroGenics (MGNX) | United States | $0.193B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.153B | 0.00 |
| Veru (VERU) | United States | $0.152B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.29 |
| Jin Medical (ZJYL) | China | $0.136B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 11.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| InterCure (INCR) | Israel | $0.078B | 0.00 |
| INLIF (INLF) | $0.074B | 0.00 | |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 36.33 |
| Apyx Medical (APYX) | United States | $0.057B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |